Streetbeat News

Revenues

RXST

RxSight has projected its FY23 revenue to be between $81M and $86M, which is in line with the estimated $81.88M.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 8:58 pm

PARA

During a conference call, Paramount's CFO forecasted a 20% growth in average revenue per user on Paramount+ in 2024.

Portfolio Pulse from Charles Gross

August 07, 2023 | 8:57 pm

PARA

Paramount's CFO announced that the company will realize $2.2 billion of gross proceeds from the sale of its book publisher, as revealed during a conference call.

Portfolio Pulse from Charles Gross

August 07, 2023 | 8:55 pm

BKD

Brookdale Senior Living (BKD) anticipates a year-over-year RevPAR growth of 10.0%-10.5% for Q3. The company also expects its adjusted EBITDA to be between $73M and $78M.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 8:54 pm

SIBN

SI-BONE has increased its FY23 revenue forecast from $128M-$131M to $132M-$134M, which is higher than the estimated $130.03M.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 8:51 pm

AKYA

Akoya Biosciences has reaffirmed its FY23 revenue guidance of $95M-$98M.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 8:50 pm

AFIB

Acutus Medical has projected its FY23 revenue to be between $20M-$22M, which is higher than the estimated $19.93M.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 8:49 pm

SWAV

Shockwave Medical has projected its FY23 revenue to be between $725M and $730M, which is higher than the estimated $716.1M.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 8:46 pm

KD

Kyndryl has reaffirmed its constant-currency revenue outlook and its FY24 targets for benefits from its Three-A initiatives. The company also expects its adjusted free cash flow to be positive.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 8:46 pm

ADEA

Adea has reaffirmed its revenue outlook for FY23, expecting to generate between $385M and $415M.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 8:46 pm